| Name | Title | Contact Details |
|---|
Xenon Pharmaceuticals (NASDAQ:XENE) – a biopharmaceutical company with operations in Vancouver, BC, Canada and Boston, MA, U.S.A. – is committed to delivering innovative medicines to provide a brighter future for patients suffering from neurological disorders. At Xenon, we are advancing an exciting pipeline of neurology-focused therapies, with a particular emphasis on novel treatments for both adult and pediatric patients with epilepsy. XEN496 is currently being evaluated in the Phase 3 “EPIK” clinical trial in young patients with KCNQ2-DEE, a rare and severe form of childhood epilepsy. Late-stage development plans are also underway for our XEN1101 program, building upon the compelling data from the Phase 2b “X-TOLE” study in adult patients with focal epilepsy. We are also proud of the leading-edge science coming out of our discovery labs, with many early-stage research programs underway. In addition to Xenon`s proprietary programs, we have ongoing collaborations with our valued pharmaceutical partners. With a healthy balance sheet to support our growth plans, we continue to build a fully-integrated, premier neuroscience company with strong discovery, development, and commercial operations. Our employees are smart, passionate, dedicated, and driven by their incredibly important work to discover, develop, and deliver new medicines for patients in need. Building and maintaining a respectful, collaborative, inclusive, and productive culture is a priority for us. We are looking for great people who thrive in a fast-paced, dynamic work environment to join our team during this transformative time for Xenon.
PerkinElmer is a company that provides scientific solutions to help labs achieve their objectives efficiently and sustainably.
QSpex embodies the ideal to provide its capital partners best-in-class financial returns, and its customers distinguishable and meaningful value. We will deliver on these fundamentals, while delivering on a higher purpose, advancing the eco-system at-large. We will do this through an inspired vision, integrated ideals, an accountable organization and compassionate leadership.
Care delivery has become dysfunctional. Its fragmented, impersonal, and expensive — but it doesnt have to be. PinpointCare is a cloud-based, flexible SaaS solution that gives healthcare professionals the power to coordinate care across the entire continuum without disrupting their workflow. Patients are engaged in creating personalized care plans and information is shared across sites of care, enabling healthcare providers to make informed decisions to better manage risk, reduce costs and improve quality.
At California Hospital Association (CHA), we collaborate with our members to provide strong and effective representation and advocacy to advance the interests of California hospitals, patients and communities. CHA is a trusted resource, working with members to achieve legislative, regulatory, and legal accomplishments at the state and federal level. Based in Sacramento, CHA is the statewide leader representing the interests of more than 400 hospitals and health systems in California.